Medical Marijuana, Inc. is a company that carved out a significant section of a highly competitive market in 2016 and 2017, and it stands to gain even more traction on the international market in the years to come. A major international move for the company promises to expand its market share and yield new growth opportunities in a global sphere.

Medical Marijuana Markets in the United States

It is estimated that the legal marijuana industry has a value of $7.1 billion in the United States alone. This figure is expected to see continued growth throughout the remainder of 2017 and well into 2018 as the American public and medical community become more aware of the benefits of CBD oil products. While this figure includes both legal recreational and medicinal use in the United States, medical marijuana products show unprecedented potential for market growth due to their versatile treatment indications.

Worldwide Market Opportunity for Medical Marijuana, Inc.

It is no secret that attitudes toward medical marijuana are changing around the world. A recent statement from the World Anti-Doping Agency has made significant waves in the commercial marijuana product industry, and for good reason. The WADA was created by the International Olympic Committee to oversee the use of drugs in professional athletics. Cannabidiol was originally on the list of the WADA’s banned substances, but that will change in 2018.

With the removal of CBD from the WADA’s list of banned substances, hemp oil products such as the ones MJNA produces will no longer face the stigma associated with other banned substances. Because Real Scientific Hemp Oil-X and other products offered through the RSHO product line are scientifically formulated to provide consistent results without the high typically associated with other marijuana products, they present an excellent option for athletes. Currently, RSHO-X is the only hemp oil product that is recognized as 100-percent THC-free by international governmental organizations.

Why THC-Free Matters

THC, also known as tetrahydrocannabinol, is a psychoactive compound found naturally in marijuana. Because RSHO-X products are specifically formulated to provide the benefits of hemp oil without the presence of THC and its associated effects, they have been approved by both the Brazilian and Medical governments for multiple treatment indications. The stigma attached to medical marijuana stems largely from its association with regular marijuana’s psychotropic effects. However, patients who take THC-free hemp oil products do not experience these effects and are not inhibited in their daily activities as a result. MJNA‘s formulation process is geared toward precision and purity, giving peace of mind to professional athletes and anyone else who requires completely THC-free products to meet regulatory standards.

The Global Potential for Treatment

MJNA’s products have been clinically tested for use in the treatment of various conditions, such as cancer-related pain, diabetic neuropathy, multiple epileptic conditions, skin conditions such as psoriasis, and many others. Clinical testing is the key to gaining more traction in the international market as it provides hard evidence international governments and medical policymakers can use to determine if a product is safe and effective. As more international medical communities come to acknowledge the medicinal and therapeutic potential of CBD hemp oil, legal permissions will continue to expand, in turn expanding the global market potential.

RSHO-X products have also shown significant potential in the treatment of pediatric conditions, such as epilepsy. Because of the THC-free formulation, pediatric physicians around the world are realizing the benefits of these products in a pediatric treatment setting. High-profile cases of government approval and WADA’s updated banned substances list provide even more opportunities to educate the global public about this product potential.

WADA Studies in 2015

In 2015, WADA conducted studies with more than 300,000 athletes from around the world. Approximately 4 percent of the athletes tested returned positive results for cannabinoids. While the presence of cannabinoids would have once been grounds for immediate disqualification from athletic competition, the new WADA regulations will make it possible for athletes who take THC-free CBD oil to compete competitively. This is a vital development for companies like MJNA as the sports nutrition market is estimated to grow from 11 billion to 14 billion by 2019.

With a varied product pipeline, MJNA stands ready to dominate this emerging market. The company offers hemp CBD oil in a variety of formulations and delivery mechanisms, including capsules, sublingual oil, concentrates, tinctures and drops. This makes it possible for consumers around the world to reap the benefits of CBD oil in a discreet and reliable way.

About the Author

Stuart Smith is the CEO and Founder of is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about and their services, please visit